IV Colistin for Pulmonary Exacerbations: Improving Safety and Efficacy
Phase: PHASE4
Conditions: Cystic Fibrosis
Sponsor: National Jewish Health

 
IRB APPROVED
11/24/2020

 
IRB APPROVED
11/24/2020

 
IRB APPROVED
11/24/2020

 
IRB APPROVED
11/24/2020

 
IRB APPROVED
11/24/2020

 
IRB APPROVED
11/24/2020

 
IRB APPROVED
11/24/2020

 
IRB APPROVED
11/24/2020

 
IRB APPROVED
11/24/2020

 
IRB APPROVED
11/24/2020

 
IRB APPROVED
11/24/2020

 
IRB APPROVED
11/24/2020

 
IRB APPROVED
11/24/2020

 
IRB APPROVED
11/24/2020

 
IRB APPROVED
11/24/2020

 
IRB APPROVED
11/24/2020

 
IRB APPROVED
11/24/2020

 
IRB APPROVED
11/24/2020

 
IRB APPROVED
11/24/2020

 
IRB APPROVED
11/24/2020

 
IRB APPROVED
11/24/2020

 
IRB APPROVED
11/24/2020

 
IRB APPROVED
11/24/2020

 
IRB APPROVED
11/24/2020

 
IRB APPROVED
11/24/2020

 
IRB APPROVED
11/24/2020

 
IRB APPROVED
11/24/2020

 
IRB APPROVED
11/24/2020

 
IRB APPROVED
11/24/2020

 
IRB APPROVED
11/24/2020

 
IRB APPROVED
11/24/2020

 
IRB APPROVED
11/24/2020

 
IRB APPROVED
11/24/2020

 
IRB APPROVED
11/24/2020

 
IRB APPROVED
11/24/2020

 
IRB APPROVED
11/24/2020

 
IRB APPROVED
11/24/2020

 
IRB APPROVED
11/24/2020

 
IRB APPROVED
11/24/2020

 
IRB APPROVED
11/24/2020

 
IRB APPROVED
11/24/2020